Bill Baruch Likes AbbVie’s Breakout as Humira Losses Get Replaced
Bill Baruch is looking at AbbVie as a healthcare name outside of the tech trade. He pointed to 7 percent earnings growth and an expected 24 percent revenue growth ahead, with Skyrizi and Rinvoq now making up for the revenue AbbVie lost as Humira came off patent. The stock is only up about 7 percent […]
Bill Baruch’s Final Trade: Nebius Group Set to Snap Back
Bill Baruch joined CNBC’s Halftime Report for his final trade, picking Nebius Group. He calls it an AI infrastructure name with an ultra growth story that has sold off nearly half from its recent high into major support. He thinks that it snaps back quickly, though he flagged it as one of the more volatile […]
Micron’s Pop Signals Capitulation on CapEx Fears, Says Bill Baruch
Bill Baruch flagged Micron as a signal he’s been watching for a couple of weeks. After its last earnings report, memory stocks including Micron ran the following day, and he reads that move as capitulation on the market’s fear around AI CapEx spending. It’s part of a broader thesis he holds on the Mag Seven […]
Bill Baruch Defends His Gold Trade: Rebalancing Into Miners and Betting the Fed Blinks
Bill Baruch joined CNBC’s Halftime Report to defend his gold position after a rough quarter for the metal. Earlier this year, he trimmed GDX and sold CEF, a gold and silver combo fund, to move into OUNZ, a gold only vehicle. Now he says he’s stepping back in to buy more of both GDX and […]
This Selloff Looks Like August — Bill Baruch Stays Bullish but Wants Proof
Bill Baruch thinks the selloff got exacerbated — exploding put volume, leveraged ETF selling, and profit-taking after tech charts ran straight up to the right. He’s comparing it to August 2024’s sharp drop that became the low before the summer rally kicked in. But he’s not fully convinced yet: he needs to see healthcare and […]
Gridlock in Global Trade Cratering Markets
Amid blocked money flows and market stress, Bill Baruch says metals are under pressure and cash is emerging as a smarter short‑term play. Watch the full discussion here. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway
The Investment Committee give you their top stocks to watch for the second half. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Blue Line Capital Purchases Cybersecurity
Tune in as Bill Baruch joins the Halftime Report to discuss a new cybersecurity purchase.
Why is Crude Oil Strengthening?
Bill Baruch joins Schwab Network to discuss this morning’s market expectations. [TRANSCRIPT] Welcome back to the second half of the future show. We’re less than 60 minutes away from the cash open for stocks on Wall Street. Futures still suggesting a bit of a rebound after yesterday’s selling. We’ve got while the indices green arrows […]
Trade Tracker: Bill Baruch Trims Tech
Bill joined CNBC’s Halftime Report to discuss trimming in tech positions. [TRANSCRIPT] I like the story. I like the relative valuation. Maybe you’re buying a little bit of what another committee member is selling because we do have somebody who’s taking profits in some of the biggest names in this market. Bill Baruch joins us […]